Prospective noninterventional study on the use of panitumumab monotherapy in patients with recurrent or progressive colorectal cancer: the VECTIS study.

Cancer Manag Res · 2015 · PMC4627397 · PMID 26566372

Europe PMC DOI

hedged sentence

0.0745

closest p · 1.5× alpha

0.0745

boldest claim

The sentences

a nonsignificant trendP =0.0745so close (0.05 < p ≤ 0.1)

In addition, patients with fewer prior chemotherapy regimens (≤3 vs >3) showed a nonsignificant trend toward improved tumor response ( P =0.0745) and FFP ( P =0.0570).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.